Market
In Australia (AU), dried chamomile is primarily sold as a herbal infusion/tea ingredient and botanical used in retail wellness-style products. Supply is shaped by imports that must meet Australia’s biosecurity entry conditions for plant and plant products, with DAFF BICON requirements focused on contamination risks such as weed seeds and live insects. Downstream handling emphasizes maintaining dryness and cleanliness to protect aroma and reduce mould/quality loss during storage and distribution. Food-market compliance is governed by the FSANZ Food Standards Code (including residue-related requirements where applicable), and products marketed with therapeutic claims may fall under TGA oversight.
Market RoleImport-oriented consumer market
Domestic RoleHerbal infusion/tea ingredient market for retail, foodservice, and blending/packing
Risks
Biosecurity HighBiosecurity non-compliance is the primary deal-breaker risk: contamination of dried chamomile with weed seeds, live insects, soil, or other quarantine material can trigger DAFF intervention (holds, treatment directions, re-export, or destruction) under Australia’s biosecurity import conditions.Screen against DAFF BICON before contracting; require supplier cleaning/foreign-matter controls and documented pest management; align on packaging and inspection-ready lots; verify whether a phytosanitary certificate or permit is required for the origin/presentation.
Food Safety MediumChemical and contaminant non-compliance (e.g., residues that breach applicable requirements for foods) can lead to import clearance delays, rejection, or downstream recall risk in Australia.Implement pre-shipment testing aligned to the intended Australian market use (food/herbal infusion), and maintain documented batch traceability and supplier specifications consistent with FSANZ Food Standards Code expectations.
Regulatory Compliance MediumRegulatory perimeter risk: chamomile positioned as a food must meet FSANZ requirements, while products marketed with therapeutic claims may trigger TGA regulatory obligations, affecting allowable claims, presentation, and compliance workload.Decide early whether the product is supplied as a food (herbal infusion) or as a therapeutic good; align labelling and claims to the correct regulator (FSANZ vs TGA) before import and retail launch.
Logistics MediumSea-freight volatility and port disruptions can raise landed costs and extend lead times for dried botanicals, increasing inventory risk and working-capital requirements for Australian importers.Use contracted freight where feasible, consolidate shipments, and maintain buffer stock sized to expected shipping variability for the chosen origin-to-Australia route.
Sustainability- Invasive species and weed-seed pathway control is a central environmental theme for imported dried plant products into Australia under the national biosecurity regime.
Labor & Social- Modern slavery due-diligence expectations may apply for Australian buyers (including mandatory reporting for entities covered by Australia’s Modern Slavery Act 2018), depending on the upstream country-of-origin risk profile for agricultural supply chains.
FAQ
What is the biggest risk that can block dried chamomile imports into Australia?Biosecurity non-compliance is the main deal-breaker: if shipments contain weed seeds, live insects, soil, or other quarantine material, Australia’s biosecurity authorities can hold the goods and direct actions such as treatment, re-export, or destruction. Importers typically manage this by following DAFF BICON conditions and tightening supplier cleaning and contamination controls.
Which Australian authorities matter most for compliance if chamomile is sold as a tea or herbal infusion?For chamomile sold as a food (e.g., herbal infusion/tea), the key baseline requirements are set by the FSANZ Food Standards Code. For import entry conditions on plant products (including contamination risks like weed seeds and live insects), DAFF biosecurity requirements in BICON are central.
When could chamomile products fall under TGA regulation in Australia?If the product is marketed or supplied with therapeutic claims (rather than as a food), it may fall within the Therapeutic Goods Administration (TGA) framework, which can change the compliance expectations for product claims and presentation.